HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.

AbstractOBJECTIVES:
Because systemic vasculitis (SV) predisposes to atherosclerosis, and high-density lipoprotein (HDL) prevents atherosclerosis by "reverse cholesterol transport" and by inhibiting low-density lipoprotein (LDL) oxidation thanks to apolipoprotein A-I (Apo-AI) and paraoxonase 1 (PON1), we assessed whether LDL oxidation was increased in SV and associated with less PON1 activity.
METHODS:
The sera of 33 patients with active SV (ASV), 32 in full remission of SV (RSV) and 20 healthy subjects (HS) were analyzed for C-reactive protein (CRP), high-sensitivity-CRP, lipids, lipoproteins, apolipoproteins, PON1 activity, LDL-immune complexes (LDL-IC), and auto-antibodies to oxidized-LDL (ox-LDL), and anticardiolipin antibodies.
RESULTS:
CRP was higher in ASV than RSV and HS, and negatively correlated with HDL-cholesterol and Apo-AI. Autoantibodies to ox-LDL and highly oxidized malondialdehyde-LDL were higher in RSV than ASV and HS (P<0.05). LDL-IC titers were higher in ASV than RSV and HS (P<0.05). PON1 activity was lower in ASV and RSV than HS (P=0.02). A trend toward a negative correlation between basal PON1 activity and anti-MDA-LDL antibodies (P=0.06) was observed.
CONCLUSION:
Inflammatory markers in SV were associated with a modified lipoprotein profile, which could lower PON1 activity and contribute to increased ox-LDL titers and accelerated atherosclerosis development.
AuthorsThomas Quéméneur, Françoise Martin-Nizard, Abdelmejid Kandoussi, Xavier Kyndt, Philippe Vanhille, Eric Hachulla, Pierre-Yves Hatron, Jean-Charles Fruchart, Patrick Duriez, Marc Lambert
JournalSeminars in arthritis and rheumatism (Semin Arthritis Rheum) Vol. 37 Issue 3 Pg. 149-55 (Dec 2007) ISSN: 0049-0172 [Print] United States
PMID17512573 (Publication Type: Journal Article)
Chemical References
  • Apolipoprotein A-I
  • Autoantibodies
  • Biomarkers
  • Cholesterol, HDL
  • Lipoproteins, LDL
  • malondialdehyde-low density lipoprotein, mouse
  • oxidized low density lipoprotein
  • Malondialdehyde
  • C-Reactive Protein
  • Aryldialkylphosphatase
  • PON1 protein, human
Topics
  • Aged
  • Apolipoprotein A-I (blood)
  • Aryldialkylphosphatase (blood)
  • Atherosclerosis (blood, immunology)
  • Autoantibodies (blood)
  • Biomarkers (blood)
  • C-Reactive Protein (metabolism)
  • Cholesterol, HDL (blood)
  • Female
  • Humans
  • Lipoproteins, LDL (blood, immunology, metabolism)
  • Male
  • Malondialdehyde (analogs & derivatives, blood, immunology)
  • Middle Aged
  • Oxidative Stress
  • Vasculitis (blood, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: